QUOTE AND NEWS
Bloomberg  5 min ago  Comment 
NPS Pharmaceuticals Inc. won U.S. approval for the first drug to treat a rare hormonal abnormality, vindicating Shire Plc’s gamble to buy the company for $5.2 billion before the outcome was publicly known.
Benzinga  Jan 13  Comment 
In a report published Tuesday, Barclays Capital analyst Geoffrey Meacham downgraded the rating on NPS Pharmaceuticals (NASDAQ: NPSP) from Overweight to Equal-Weight, and lowered the price target from $50.00 to $46.00. In the report, Barclays...
TheStreet.com  Jan 12  Comment 
NEW YORK (TheStreet) - NPS Pharmaceuticals shares surged more than 8% on Monday after Dublin's Shire announced it plans to acquire the Bedminster, N.J.-based biopharmaceutical company for $5.2 billion. Shire will acquire all outstanding...
Benzinga  Jan 12  Comment 
Following the market opening Monday, the Dow traded down 0.77 percent to 17,601.64 while the NASDAQ slipped 0.88 percent to 4,662.69. The S&P also fell, dropping 0.93 percent to 2,025.80. Leading and Lagging Sectors In trading on Monday,...
TheStreet.com  Jan 12  Comment 
NEW YORK (TheStreet) -- NPS Pharmaceuticals  shares are up 8.2% to $45.36 on heavy volume in early market trading today after the company agreed to be bought by Britain's Shire plc yesterday for $5.2 billion. The purchase price comes to...
Benzinga  Jan 12  Comment 
NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) surged 8.23% to $45.36. The volume of NPS Pharmaceuticals shares traded 9376% higher than normal. Shire PLC (NASDAQ: SHPG) agreed to buy NPS Pharmaceuticals for $5.2 billion, or $46 per share. ...
Benzinga  Jan 12  Comment 
In a report published Monday, Jefferies analyst Eun K. Yang reiterated a Hold rating on NPS Pharmaceuticals, Inc. (NASDAQ: NPSP), and raised the price target from $26.00 to $46.00. In the report, Jefferies noted, “Shire's proposed acquisition...
Benzinga  Jan 12  Comment 
Analysts at Canaccord Genuity downgraded NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) from Buy to Hold. The price target for NPS Pharmaceuticals is set to $42. NPS Pharmaceuticals shares have jumped 19.74% over the past 52 weeks, while the S&P...
Benzinga  Jan 12  Comment 
The Economic Times  Jan 12  Comment 
Traders also cited a $5.2 billion takeover by London-listed drugmaker Shire Plc of U.S. group NPS Pharmaceuticals as a negative factor for sterling.
Benzinga  Jan 12  Comment 
The following are the M&A deals, rumors and chatter circulating on Wall Street for Friday January 9 through Sunday January 11, 2015 Shire to Acquire NPS Pharma for $46.00/Share The Deal: Shire plc (NASDAQ: SHPG) and NPS Pharmaceuticals, Inc....





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki